Exploring Immunotherapy Esophageal And Gastric Cancer
Exploring Immunotherapy Esophageal And Gastric Cancer reveals several interesting facts.
- Maria Svensson, MD, Lund University, discusses the associations of PD-1 and PD-L1 expression with mismatch repair status and ...
- Yelena Y. Janjigian, MD, medical oncologist, Memorial Sloan Kettering
- Dr. Shah Discusses Challenges With Immunotherapy in Esophageal Cancer
- Co-Chairs Jaffer A. Ajani, MD, and Ian Chau, MD, FRCP, discuss GI
- In this webinar for
In-Depth Information on Immunotherapy Esophageal And Gastric Cancer
Ramon De Mello, MD, PhD, FACP, of the University of Algarve, Faro, Portugal, discusses whether Immunotherapy Geoffrey Y. Ku, MD, medical oncologist at Memorial Sloan Kettering This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...
Deepa Magge, MD, FACS, Vanderbilt-Ingram
Stay tuned for more updates related to Immunotherapy Esophageal And Gastric Cancer.
